Change of PML/PML-RARalpha protein during treatment with tetraarsenic tetrasulfide (As4S4) in patients with acute promyelocytic leukemia

Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology

Volumn 11, Issue 5, 2003, Pages 464-468

  Wang, Jing Zhi ^a   Liu, Yan Rong ^a   Qin, Ya Zhen ^a   Jiang, Hao ^a   Wang, Feng Rong ^a   Bao, L ^a   Lu, Dao Pei ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; NUCLEAR PROTEIN; ONCOPROTEIN; ORGANOARSENIC DERIVATIVE; PML PROTEIN, HUMAN; PROMYELOCYTIC LEUKEMIA RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA-RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; RETINOIC ACID; TRANSCRIPTION FACTOR; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NICK END LABELING; PROMYELOCYTIC LEUKEMIA;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; ARSENICALS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IN SITU NICK-END LABELING; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; TRANSCRIPTION FACTORS; TRETINOIN; TUMOR SUPPRESSOR PROTEINS;

EID: 2142742362     PISSN: 10092137     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)